Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology

被引:0
作者
Carlos M. Ferrario
机构
[1] Wake Forest University Health Science Center,Hypertension and Vascular Disease Center
来源
Current Hypertension Reports | 2003年 / 5卷
关键词
Angiotensin; Angiotensin Converting Enzyme; Losartan; Bradykinin; Neutral Endopeptidase;
D O I
暂无
中图分类号
学科分类号
摘要
Increased understanding of the contribution of angiotensin peptides to the physiologic control of arterial pressure and cardiovascular regulation has been made possible with the introduction of agents that either inhibit the activity of angiotensins forming enzymes or block the action of the peptides at their specific receptor subtypes. This review highlights some of the lessons that have been learned from the study of the actions of angiotensin-(1-7) and its interrelationship with other vasodilator mechanisms that modulate the control systems that determine blood pressure and tissue perfusion. The studies suggest that the reninangiotensin system acts as a humoral mechanism for blood pressure control through the generation of several distinct forms of angiotensin peptides that may bind to diverse receptor subtypes.
引用
收藏
页码:129 / 134
页数:5
相关论文
共 144 条
[21]  
Hales P(1998)Vasodepressor actions of angiotensin-(1–7) unmasked during combined treatment with lisinopril and losartan Hypertension 31 699-705
[22]  
Kaushik V(1998)Angiotensin-(1–7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system Hypertension 31 356-361
[23]  
Donoghue M(1995)Angiotensin-(1–7) potentiates the hypotensive effect of bradykinin in conscious rats Hypertension 26 1154-1159
[24]  
Hsieh F(1999)Potentiation of the hypotensive effect of bradykinin by angiotensin-(1–7)-related peptides Peptides 20 493-500
[25]  
Baronas E(1998)Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery J Pharmacol Exp Ther 286 403-410
[26]  
Chappell MC(2001)Potentiation of bradykinin by angiotensin-(1–7) on arterioles of spontaneously hypertensive rats studied in vivo Hypertension 37 703-709
[27]  
Jung F(1995)Metabolism of angiotensin I in isolated rat hearts. Effect of angiotensin converting enzyme inhibitors Biochem Pharmacol 50 1451-1459
[28]  
Gallagher PE(2001)Angiotensin (1–7) potentiates bradykinin-induced vasodilatation in man J Hypertens 19 2001-2009
[29]  
Urata H(1999)Synergistic effect of angiotensin-(1–7) on bradykinin arteriolar dilation in vivo Peptides 20 1195-1201
[30]  
Kinoshita A(2000)Angiotensin-(1–7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart Braz J Med Biol Res 33 709-713